123 related articles for article (PubMed ID: 11853610)
21. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
22. [The correlation between expression of oncogene protein products p53, p21, p185 and cell differentiation and prognosis in rhabdomyosarcoma].
Lai R; Luo Z; An J
Zhonghua Bing Li Xue Za Zhi; 1997 Feb; 26(1):35-7. PubMed ID: 10072848
[TBL] [Abstract][Full Text] [Related]
23. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart.
Garcia JM; Gonzalez R; Silva JM; Dominguez G; Vegazo IS; Gamallo C; Provencio M; España P; Bonilla F
Br J Cancer; 2000 Mar; 82(6):1183-5. PubMed ID: 10735503
[TBL] [Abstract][Full Text] [Related]
24. [Detection of the expression of P21, P53, P185 proteins and the mutation of ras, p53 genes in colorectal adenoma and carcinoma].
Liang Z; Liu F; Luo Y
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):352-5. PubMed ID: 8732090
[TBL] [Abstract][Full Text] [Related]
25. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
[TBL] [Abstract][Full Text] [Related]
27. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
28. Oncogene amplification and overexpression of oncoproteins in thyroid papillary cancer.
Várkondi E; Gyory F; Nagy A; Kiss I; Ember I; Kozma L
In Vivo; 2005; 19(2):465-70. PubMed ID: 15796211
[TBL] [Abstract][Full Text] [Related]
29. N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders.
Tsurumi S; Nakamura Y; Maki K; Omine M; Fujita K; Okamura T; Niho Y; Hashimoto S; Kanno K; Suzuki K; Hangaishi A; Ogawa S; Hirai H; Mitani K
Am J Hematol; 2002 Oct; 71(2):131-3. PubMed ID: 12353315
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
[TBL] [Abstract][Full Text] [Related]
33. [Expression of p53 and ras p21 gene products in malignant transformed V79 cell induced by various organic components of DEPs].
Lü Y; Ding X; Ye S
Wei Sheng Yan Jiu; 1998 Jul; 27(4):224-6. PubMed ID: 10682588
[TBL] [Abstract][Full Text] [Related]
34. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of mdm2 and p53 expression in orbital rhabdomyosarcoma].
Xu XL; Li B; Sun XL; Li LQ
Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):755-9. PubMed ID: 15634483
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.
Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; Tomasino RM; Colomba P; Tagliavia M; La Farina M
Biochem Biophys Res Commun; 2004 Dec; 325(3):784-91. PubMed ID: 15541358
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
38. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
